None listed
Conditions
Interventions
Intervention1: Caffeine SR Natcaff Capsule: A Single oral dose of Caffeine SR Natcaff Capsule will be administered in each period Total Duration of the study is 10 Days
Control Intervention1: Caffeine
Sponsors
Ambe Phytoextracts
Spinos Life Science and Research Private limited
Eligibility
Inclusion criteria
Inclusion criteria: Normal healthy adult human trial participants of age between 18 to 45 years and Body Mass Index BMI ranges between 18.50 kg/m2 to 30.00 kg/m2 Trial participants who have no evidence of underlying disease during screening and check in and whose screening is performed within 21 days of check in Trial participants whose screening laboratory values are within normal limits are considered by the principal or clinical investigator to be of no clinical significance Healthy as documented by the medical history physical examination including but not limited to an evaluation of the cardiovascular gastrointestinal respiratory musculoskeletal and central nervous system and vital sign assessments Generally healthy as documented by a 12 lead electrocardiogram ECG Chest X Ray and clinical laboratory assessments Willing to consume non vegetarian diet Willing to comply with all requirements of this study protocol as well as instructions from the study personnel Non smokers Generally healthy as documented by gynaecological examination and breast examination for female Trial participants period I only Females of childbearing potential must have a negative serum pregnancy test performed within 21 days prior to the initiation of the study and a negative urine pregnancy test prior to check in for each period If the Trial participant is female, currently not pregnant not lactating or not attempting to become pregnant for 4 weeks before the screening visit throughout the duration of the study and 3 weeks after the Trial participants last study related visit for eligible Trial participants only if applicable has a negative serum pregnancy test and is of non-childbearing potential defined as less than 1 year post menopausal no menstrual period for at least 12 consecutive months without any other medical cause Surgically sterile bilateral tubal ligation bilateral oophorectomy or hysterectomy or is of childbearing potential willing to commit to using a consistent and acceptable method of birth control as defined below for the duration of the study double barrier methods condoms cervical cap diaphragm and vaginal contraceptive film with spermicide intrauterine device IUD with a low failure rate of less than 1 percent per year or is of childbearing potential and not sexually active willing to commit to using a consistent and acceptable method of birth control as defined above for the duration of the study in the event the Trial participant becomes sexually active
Exclusion criteria
Exclusion criteria: Evidence of allergy or known hypersensitivity to Caffeine or its inactive ingredients Trial participants with hepatic encephalopathy cholestasis myasthenia pre existing liver disease alcohol abuse existing tinnitus and pre existing gallbladder disease Any major illness in the last three months or any significant ongoing chronic medical illness Renal or liver impairment Any disease or condition that might compromise the haemopoeitic gastrointestinal renal hepatic cardiovascular Musculoskeletal respiratory central nervous system or any other body system including presence of Diabetes Mellitus and Psychosis History of alcohol addiction or abuse Consumption of caffeine and or xanthine containing products ie coffee tea chocolate caffeine containing sodas colas etc cigarettes and tobacco containing products for at least 48.00 hours prior to check in of each period and until completion of the study Consumption of alcohol and its products grapefruit and or its juice and poppy containing foods within 48.00 hours prior to clinic admission and until completion of the study Trial participants who have taken any prescription medications within 14 days prior to study check in and throughout the study and any over the counter medicinal products herbal medications within 07 days prior to study check in of each period and until completion of the study Trial participants who have taken any unusual diet for whatever reason eg low salt for 48.00 hours prior to dosing and until completion of the study Trial participant who had participated in any other study within the 90 days of check in History of difficulty in swallowing History of difficulty in accessibility of veins Positive results for urine screen of drugs of abuse Marijuana THC amphetamine AMP barbiturates BAR cocaine COC benzodiazepines BZD and morphine MOR in urine prior to check in of each period Positive results for alcohol test prior to check in of each period Any blood donation excess blood loss within 90 days of check in Ingestion of any hormonal agent at any time within 14 days prior to the start of the study check in Use of hormone replacement therapy for a period of 06 months prior to dosing Female Trial participants demonstrating a positive pregnancy screen Female Trial participants who are currently lactating Females are likely to become pregnant during the course of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the Pharmacokinetics of Caffeine SR Natcaff with Caffeine IR In healthy adult human trial participants under fasting conditionsTimepoint: 14 Time points 00.00 Hrs 00.25 Hrs 00.50 Hrs 00.75 Hrs 01.00 Hrs 01.50 Hrs 02.00 Hrs 03.00 Hrs 04.00 Hrs 06.00 Hrs 08.00 Hrs 10.00 Hrs 12.00 Hrs 24.00 Hrs | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the changes in Caff VAS Questionnaire between Caffeine SR Natcaff with Caffeine IR in healthy adult human trial participants under fasting conditions To monitor the safety and tolerability of test product comparing with the reference product in healthy adult human trial participants under fasting conditionsTimepoint: 14 Time points 00.00 Hrs 00.25 Hrs 00.50 Hrs 00.75 Hrs 01.00 Hrs 01.50 Hrs 02.00 Hrs 03.00 Hrs 04.00 Hrs 06.00 Hrs 08.00 Hrs 10.00 Hrs 12.00 Hrs 24.00 Hrs | — |
Countries
India
Contacts
Public ContactDr Pradeep T
Spinos Life science and research private limited
Outcome results
None listed